Shanghai Conant Optical Co., Ltd. provides earnings guidance for the year ended 31 December 2022. The Group is expected to record an increase of no less than 30% in net profit attributable to shareholders for the year ended 31 December 2022, as compared to that for the year ended 31 December 2021. The increase was mainly attributable to (i) an increase in revenue as a result of an increase in the sale volume of resin spectacle lens; (ii) an increase in exchange gain arising from the appreciation of U.S. dollar against Renminbi; and (iii) a decrease in finance costs due to the repayment of interest-bearing bank borrowings and the reduction in the interest rates of bank borrowing.
Shanghai Conant Optical Co., Ltd.
Equities
2276
CNE100004Z14
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.84 HKD | -0.37% | +6.27% | +53.54% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+53.54% | 589M | |
+13.05% | 101B | |
+21.66% | 44.15B | |
-20.19% | 2.21B | |
+21.28% | 2.1B | |
+22.95% | 1.15B | |
-40.56% | 699M | |
-44.00% | 655M | |
-10.65% | 651M | |
+19.82% | 507M |
- Stock Market
- Equities
- 2276 Stock
- News Shanghai Conant Optical Co., Ltd.
- Shanghai Conant Optical Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022